Clinical Study of PRP in the Treatment of Androgenetic Alopecia

April 19, 2026 updated by: The First Affiliated Hospital of Soochow University

The Application of Platelet-rich Plasma in the Treatment of Androgenic Alopecia：a Prospective Clinical Random Study.

A study on the therapeutic effect of platelet-rich plasma in the treatment of androgenetic alopecia

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study included 30 patients with moderate and severe androgenic alopecia and randomly divided into two groups, group A was treated with platelet-rich plasma (once 4 weeks for 3 times) combined with external Minoxidil(5% for male, 2% for female, twice a day, 1 ml each time) , group B was treated with external Minoxidil. The patients in both groups were examined by dermoscopy before the first treatment and 1,2,3 and 6 months after the treatment. The scalp MRI was performed before the first treatment and 6 months after the treatment, the number, density and depth of hair follicles were measured to evaluate the efficacy and safety of platelet-rich plasma combined with Minoxidil in the treatment of androgenic alopecia.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Jiangsu
      • Suzhou, Jiangsu, China, 215300
        • The First Affiliated Hospital of Soochow University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • moderate to severe androgenic Alopecia

Exclusion Criteria:

  • abnormal coagulation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group A
platelet-rich plasma combined with minoxidil
Drug: PRP
group A was treated with platelet-rich plasma combined with external Minoxidil , group B was treated with external Minoxidil
Other Names:
  • plitelet-rich plasma

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dermoscope
Time Frame: before the first treatment and 1,2,3 and 6 months after the treatment
The amount of hair on the parietal and posterior occipital regions
before the first treatment and 1,2,3 and 6 months after the treatment
MRI
Time Frame: before the first treatment and 6 months after the treatment
Hair follicle density on the parietal and posterior occipital regions
before the first treatment and 6 months after the treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The First Affiliated Hospital of Soochow University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Actual)

January 1, 2026

Study Completion (Actual)

March 1, 2026

Study Registration Dates

First Submitted

April 19, 2026

First Submitted That Met QC Criteria

April 19, 2026

First Posted (Actual)

April 24, 2026

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 19, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20250315

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Androgenetic Alopecia (AGA)

Clinical Trials on PRP

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe